NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Mitem Pharma

Mitem Pharma

Private
MassyHealthcare & Life Scienceshttps://www.mitempharma.com/

Last Round

Corporate Funding

Sep 25, 2024

Total Funding Raised

$10.7M

Company Overview

Mitem Pharma is a pharmaceutical company that specializes in the revitalization, development, and commercialization of drugs of major therapeutic interest (MITMs).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

Medicines of Major Therapeutic InterestMITMsspecialty pharmadrug life cycle managementdrug acquisitionfabless pharmaessential medicinesorphan drugsrare disease drugsmature drugsdrug commercializationpharma supply chainmarket accessregulatory affairshematologyendocrinology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mitem Pharma Comparables

Compare Mitem Pharma with similar companies based on industry and business-model similarity.

Mitem Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Laboratoires Delbert
86%
Essential Pharma
80%
Pharmanovia
78%

Mitem Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingSep 25, 2024
Growth EquityApr 25, 2022

Mitem Pharma Investors

Notable investors and investment history

Mitem Pharma investors
InvestorRounds
Access Capital PartnersCorporate Funding
TechLife CapitalCorporate Funding, Growth Equity
SWEN Capital PartnersCorporate Funding
MACSFCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    Monthly visitors grew 464% MoM, from 83 to 468.

  • Dec 18, 2023

    Grew 67% QoQ, from 9 to 15 employees.

Mitem Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mitem Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mitem Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersMassy
Employee Range18
Year Founded2016
Last FundingSep 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.